AKAM
Akamai Technologies, Inc.
AKAM has lower modeled downside risk, despite its lower overall score.
ASTS
AST SpaceMobile, Inc.
ASTS has a slight edge over AKAM overall, supported by stronger fundamentals and stronger modeled upside.
AKAM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weak |
AKAM's revenue, profitability and cash flow are currently stable, but its balance sheet is weak.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
AKAM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $86.56 | — |
| Cheap | 25x | $65.50 | -24% |
| Fair | 30x | $77.92 | -10% |
| Expensive | 34x | $88.53 | +2.3% |
| Current | 34x | $86.56 | — |
Historical ranges are pointers, not guarantees.
AKAM's PE is in its expensive range at 34x. On analysts' estimates for next year's earnings, today's price would be 13x, in its cheap range.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
AKAM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Growth | |
| Strongly weakening | |
| Moderate | |
| Moderate |
Analysts expect AKAM's revenue to grow, but its profitability to weaken.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
AKAM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.44 | +150% |
| Q3 2026 | $2.57 | -25% |
| Q2 2026 | $2.77 | -2.1% |
| Q1 2026 | $2.96 | -0.7% |
| Q4 2025 | $3.07 | -6.1% |
| Q3 2025 | $3.42 | +1.5% |
| Q2 2025 | $2.83 | -30% |
| Q1 2025 | $2.98 | -26% |
| Q4 2024 | $3.27 | -7.1% |
AKAM has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
AKAM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +6.4% |
| Q2 2026 | $1.1B | +5.4% |
| Q1 2026 | $1.1B | +5.8% |
| Q4 2025 | $1.1B | +7.4% |
| Q3 2025 | $1.1B | +5% |
| Q2 2025 | $1B | +6.5% |
| Q1 2025 | $1B | +2.9% |
| Q4 2024 | $1B | +2.5% |
AKAM's revenue has grown year over year every quarter since late 2020: $1.1B last quarter, up 6.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.7% | -6.1 points |
| Q2 2026 | 7.3% | -7.2 points |
| Q1 2026 | 11% | -4.6 points |
| Q4 2025 | 8.7% | -5.8 points |
| Q3 2025 | 16% | +8.7 points |
| Q2 2025 | 15% | -0.6 points |
| Q1 2025 | 15% | -1.7 points |
| Q4 2024 | 15% | -4.1 points |
AKAM has the edge over ASTS on profitability, with a higher operating margin.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
AKAM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$81.9M | -125% |
| Q2 2026 | $181.3M | -42% |
| Q1 2026 | $210.8M | +58% |
| Q4 2025 | $234.9M | -6.4% |
| Q3 2025 | $329.1M | +18% |
| Q2 2025 | $313.6M | -7.8% |
| Q1 2025 | $133.4M | -48% |
| Q4 2024 | $250.9M | -21% |
AKAM has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
AKAM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.6% | -2.5M shares |
| 1 year | +4.4% | +6.4M shares |
| 3 years | -2.5% | -3.8M shares |
| 5 years | -9.1% | -15.2M shares |
| Available history | -8.1% | -13.4M shares |
AKAM has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $409.9M |
| Q1 2026 | $205.9M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $300M |
| Q1 2025 | $500M |
| Q4 2024 | $138.4M |
AKAM spent $616M buying back its own shares over the past year, down 34% from the year before.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
AKAM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.6x | High |
| Q2 2026 | 5.1x | High |
| Q1 2026 | 2.8x | Moderate |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 2.4x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.1x | Moderate |
| Q4 2024 | 2.6x | Moderate |
AKAM's net debt is about 5.6 years of its operating earnings (EBITDA), up from 2.4 years a year ago.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
AKAM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.1 | Neutral |
| Stochastic | 15.0 | Oversold |
AKAM's weekly RSI is 39 (neutral) and its Stochastic is 15 (oversold).
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
AKAM PE vs Technology Sector
| Metric | AKAM | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 28x | 21% above |
| PE % | 79 | 35 | 44 pts above |
AKAM is trading at 34x earnings, a 21% premium to the Technology sector's median of 28x.
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
AKAM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $96.7 | 10% below |
| 20 week MA | $106.7 | 19% below |
| 50 week MA | $107.8 | 20% below |
| 100 week MA | $94.7 | 8.6% below |
| 200 week MA | $96.5 | 10% below |
AKAM is in a downtrend: it's below all five of its weekly moving averages, and 10% below its 200-week average.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over AKAM on trend strength, trading above more of its moving averages.
AKAM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $86.5 | $107.5 | +24% |
| 2021 | $107.5 | $116.2 | +8.1% |
| 2022 | $116.2 | $83.2 | -28% |
| 2023 | $83.2 | $118.4 | +42% |
| 2024 | $118.4 | $97.0 | -18% |
| 2025 | $97.0 | $88.4 | -8.8% |
| 2026 YTD | $88.4 | $86.6 | -2.1% |
AKAM has the edge over ASTS on returns for 2026, with the stronger performance.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.